Vylor (NYSE:VYLR) Raised to Sell at Wall Street Zen

Vylor (NYSE:VYLR – Get Free Report) was upgraded by analysts at Wall Street Zen to a “sell” rating in a research note issued on Saturday, Wall Street Zen reports.

Other analysts also recently issued research reports about the company. Royal Bank Of Canada began coverage on Vylor in a research report on Friday, October 2nd. They set an “outperform” rating and a $85.00 price target for the company. Weiss Ratings assumed coverage on shares of Vylor in a research report on Friday, October 2nd. They issued a “sell (d+)” rating on the stock. BMO Capital Markets began coverage on shares of Vylor in a research report on Friday, October 2nd. They issued an “outperform” rating and a $85.00 price objective on the stock. Mizuho started coverage on shares of Vylor in a research note on Monday, October 5th. They issued an “outperform” rating and a $84.00 target price on the stock. Finally, KeyCorp started coverage on shares of Vylor in a research report on Wednesday. They set a “sector weight” rating and a $78.00 target price for the company. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $82.00.

Get Our Latest Research Report on Vylor

Vylor Price Performance

Shares of NYSE VYLR opened at $72.82 on Friday. Vylor has a twelve month low of $65.00 and a twelve month high of $75.49.

Vylor Company Profile

(Get Free Report)

Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.

Recommended Stories

Analyst Recommendations for Vylor (NYSE:VYLR)

Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.